Sign In
Buy CDXS
$2.72
+0.0300 (+1.12%)
At Close: Jun 03, 2026
Codexis Reports First Quarter 2021 Financial Results
04:05pm, Thursday, 06'th May 2021
Total Revenue up 23% and Product Revenue Doubles Year over Year
Codexis to Report First Quarter 2021 Financial Results on May 6
04:05pm, Thursday, 22'nd Apr 2021
REDWOOD CITY, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the first quar
AstraZeneca, Bumble, McDonald's, Microsoft and More Monday Afternoon Analyst Calls
11:49am, Monday, 12'th Apr 2021
With the trading day about halfway over, the broad markets were pulling back. All the major averages were reeling, especially the Nasdaq, on concerns over the global semiconductor shortage.
Codexis, Inc.'s (CDXS) CEO John Nicols on Q4 2020 Results - Earnings Call Transcript
10:04am, Sunday, 28'th Feb 2021
Codexis, Inc.'s (CDXS) CEO John Nicols on Q4 2020 Results - Earnings Call Transcript
Codexis: Q4 Earnings Insights
04:55pm, Thursday, 25'th Feb 2021
Shares of Codexis (NASDAQ:CDXS) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 500.00% year over year to ($0.06), which beat the estimat
Codexis Reports Fourth Quarter and Fiscal Year 2020 Financial Results
04:05pm, Thursday, 25'th Feb 2021
Strong Product Revenue Momentum in Second Half of 2020 Drives Company's Seventh Consecutive Year of YOY Revenue Growth
Codexis to Present at Upcoming Virtual Healthcare Conferences
04:05pm, Thursday, 18'th Feb 2021
REDWOOD CITY, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, today announced that management will present at three upcoming virtual invest
Codexis to Report Fourth Quarter and Full Year 2020 Results on February 25
04:05pm, Thursday, 11'th Feb 2021
REDWOOD CITY, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, today announced that it will report fourth quarter and full year 2020 financi
Codexis Announces Expansion to New Facility to Accommodate Next Stage of Growth
04:05pm, Tuesday, 09'th Feb 2021
REDWOOD CITY, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, announced today it will be expanding its operations into a new 36,000 square
Codexis Appoints Dr. Esther Martinborough to its Board of Directors
04:05pm, Wednesday, 03'rd Feb 2021
REDWOOD CITY, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, today announced the appointment of Esther Martinborough, Ph.D., to its board
Codexis Introduces Improved Enzymes to Further Enhance Tate & Lyle's Stevia and Allulose Production
07:00am, Wednesday, 13'th Jan 2021
REDWOOD CITY, Calif. and HOFFMANN ESTATES, Ill., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company and developer of high-performance enzymes, and Ta
Codexis Announces Pricing of Public Offering of Common Stock
11:11pm, Wednesday, 02'nd Dec 2020
REDWOOD CITY, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 4,285,715
Codexis Announces Proposed Public Offering of Common Stock
04:25pm, Wednesday, 02'nd Dec 2020
REDWOOD CITY, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced that it has commenced an underwritten public offering of sha
Codexis to Participate at Three Virtual Investment Conferences in November
07:00am, Monday, 09'th Nov 2020
REDWOOD CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate at three upcoming virtual invest
Codexis, Inc. (CDXS) CEO John Nicols on Q3 2020 Results - Earnings Call Transcript
08:53am, Sunday, 08'th Nov 2020
Codexis, Inc. (CDXS) CEO John Nicols on Q3 2020 Results - Earnings Call Transcript
